Press releaseNewsfile
Unicycive Therapeutics
UNCY · NASDAQ
$3.80+$0.29 (+8.26%)TodayMarket closed ·
Prev close $3.51
Latest news
- Press releaseGlobe Newswire
Unicycive Therapeutics, Inc. Investors Have Until November 2nd to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
- Press releasePRNewswire
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Unicycive Therapeutics, Inc. to Contact Law Firm
- Press releaseNewsfile
UNICYCIVE DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - UNCY
- Press releaseGlobe Newswire
Deadline Alert: Unicycive Therapeutics, Inc. Investors Have Until November 2, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds
- Press releaseNewsfile
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (UNCY) Investors Seeking Recovery to Contact the Firm Before November 2, 2026
- Press releaseNewsfile
UNICYCIVE DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
- Press releaseGlobe Newswire
UNICYCIVE DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
- Press releaseNewsfile
UNICYCIVE DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
- Press releaseNewsfile
UNICYCIVE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
- Press releaseNewsfile
Kaplan Fox Advises Investors of Unicycive Therapeutics, Inc. (UNCY) of an Upcoming Securities Class Action Deadline on November 2, 2026
- Press releasePRNewswire
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 2, 2026 in Unicycive Therapeutics, Inc. Lawsuit - UNCY
- Press releaseNewsfile
UNICYCIVE DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
- Press releaseGlobe Newswire
Unicycive Therapeutics, Inc. Class Action Reminder - Robbins LLP Encourages UNCY Investors to Contact the Firm About Their Rights
- Press releaseGlobe Newswire
Deadline Alert: Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
- Press releasePRNewswire
Levi & Korsinsky Reminds Unicycive Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 2, 2026 - UNCY
- Press releasePRNewswire
Unicycive Deadline: UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
- Press releaseNewsfile
Kaplan Fox Reminds Investors of the November 2, 2026 Deadline in the Securities Class Action Against Unicycive Therapeutics, Inc. (UNCY)
- Press releaseNewsfile
Kaplan Fox Announces the Lead Plaintiff Deadline of November 2, 2026 in the Securities Class Action Against Unicycive Therapeutics, Inc. (UNCY)
- Press releasePRNewswire
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
- Press releaseGlobe Newswire
UNICYCIVE INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Unicycive Therapeutics, Inc. Investors with Large Losses to Contact the Firm Seeking Lead Plaintiff Role
- Press releasePRNewswire
UNCY Deadline Alert: SueWallSt Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of Securities Class Action Deadline on November 2, 2026
- Press releaseNewsfile
Unicycive Therapeutics, Inc. UNCY Investors with Significant Losses Encouraged to Contact Kirby McInerney LLP About Securities Class Action
- Press releasePRNewswire
Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Press releaseGlobe Newswire
UNCY SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (NASDAQ: UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
- Press releasePRNewswire
UNCY UPCOMING DEADLINE: Levi & Korsinsky Alerts Unicycive Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
- Press releaseNewsfile
Kaplan Fox Alerts Unicycive Therapeutics, Inc. (UNCY) Investors to an Approaching Lead Plaintiff Deadline on November 2, 2026
- Press releaseNewsfile
UNCY Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Securities Class Action Against Unicycive Therapeutics, Inc.
- Press releaseNewsfile
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (UNCY) to Contact the Firm Before the Securities Class Action Deadline on November 2, 2026
- Press releaseNewsfile
Kaplan Fox Reminds Unicycive Therapeutics, Inc. (UNCY) Investors to Seek a Leadership Role Before Deadline on November 2, 2026
- Press releasePRNewswire
UNCY Shareholder Alert: Unicycive Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
- Press releasePRNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 2, 2026 in Unicycive Therapeutics, Inc. Lawsuit - UNCY
- Press releaseGlobe Newswire
DEADLINE ALERT for HYLN, HIMS, UNCY, TBLA: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
- News
10 Health Care Stocks Whale Activity In Today’s Session
- NewsDaragh Thomas
Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings
- NewsAvi Kapoor
Nasdaq Gains Over 300 Points; Chicago PMI Falls In June
- NewsVandana Singh
Why Is Unicycive Therapeutics Stock Falling Tuesday?
- NewsAvi Kapoor
US Stocks Mixed; Home Prices Increase 1.1% In April
- Press releaseGlobe Newswire
Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf
- Press releaseGlobe Newswire
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf
- NewsDylan Berman
Unicycive Therapeutics Stock Is Trading Lower Tuesday: What's Going On?
- Press releaseGlobe Newswire
Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
- NewsAvi Kapoor
Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.